Search

everythinglearnresearchcommunity

for

Search:↓

Over 40% of postmenopausal women experience hair loss, with treatments aiming to stop further loss and possibly thicken hair.

Microinfusion therapy and testosterone use may cause scalp inflammation, requiring early recognition and treatment.

A patient experienced intense hair loss due to telogen effluvium after scalp contact dermatitis, but hair regrew completely within two months without further treatment.

Good scalp care and mood help prevent hair loss; medical treatment or Minoxidil may be needed.

Dermoscopy helps diagnose different hair loss conditions, and characteristics vary among ethnicities and individual cases.

Current treatments for non-scarring alopecia have limited effectiveness and side effects, while natural remedies may offer safer alternatives but need more research.

Topical minoxidil is the most promising treatment for male pattern hair loss, but more research is needed to confirm its effectiveness and safety.

The document concludes that a woman has both Frontal Fibrosing Alopecia and Lichen Simplex Chronicus, a previously unreported combination of conditions.

Frontal Fibrosing Alopecia's cause is unclear, affects mainly postmenopausal women, and current treatments focus on stopping hair loss rather than regrowth.

Scalp reduction gives the most natural result for significant crown baldness, despite potential complications, and a systematic approach to surgical hair restoration results in few complications and high graft survival.

Early diagnosis and less aggressive hair care improve outcomes for Black women with frontal fibrosing alopecia.

Alopecia areata in these mice is inherited, more common in young females, and can be treated with triamcinolone acetonide.

Trichoscopy helps tell apart other hair loss conditions from common hair loss.

Hair loss from alopecia areata and androgenetic alopecia can be treated, but more effective and safer treatments are needed.

Combining fractionated CO2 laser with tacrolimus may help treat chronic alopecia areata.

Alopecia areata's causes are unclear, treatments exist but relapses are common.

Intralesional triamcinolone is the most effective treatment for hair regrowth in alopecia areata patients.

Frontal fibrosing alopecia can be diagnosed by examining facial areas and treated with specific medications to stop its progression.

A man with a birthmark on his scalp developed hair loss that improved with treatment, but the link between the birthmark and hair loss was unclear.

A 45-year-old woman with autoimmune diseases experienced patchy hair loss due to alopecia areata, which has no cure but can be treated, with varying success.

Methotrexate may help stabilize frontal fibrosing alopecia.

Miniaturized hair follicles in androgenetic alopecia show abnormal mitochondrial activity and damage.

New alopecia treatments aim for better results and fewer side effects.

Trichoscopy is crucial for diagnosing alopecia areata by identifying specific hair features.

Tofacitinib effectively regrows hair in alopecia universalis triggered by a virus.

Both treatments for resistant alopecia areata were equally effective.

AGA causes hair loss through follicle miniaturization and hair cycle changes; regrowth depends on anagen initiation in kenogen follicles.

Hair transplant complications were likely due to deep graft placement and rough handling.

Hair loss in men treated best with early medication or transplant, new treatments researched.

Scalp reduction surgery successfully reduced baldness and improved self-image in a burn victim before hair transplantation.